Bank Of New York Mellon Corp Black Diamond Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.35 - $3.14 $24,557 - $57,119	18,191 New	18,191 $34.4 Million
Q4 2022 Feb 14, 2023	BUY	$1.27 - $2.51 $23,102 - $45,659	18,191 New	18,191 $32,000
Q2 2022 Aug 15, 2022	SELL	$1.5 - $3.63 $103,939 - $251,533	-69,293 Reduced 79.14%	18,265 $45,000
Q1 2022 May 11, 2022	SELL	$2.66 - $5.61 $5,301 - $11,180	-1,993 Reduced 2.23%	87,558 $243,000
Q4 2021 Feb 11, 2022	SELL	$5.18 - $8.48 $50,934 - $83,383	-9,833 Reduced 9.89%	89,551 $477,000
Q3 2021 Nov 12, 2021	BUY	$8.46 - $12.42 $151,340 - $222,181	17,889 Added 21.95%	99,384 $841,000
Q2 2021 Aug 11, 2021	BUY	$12.19 - $28.17 $244,055 - $563,991	20,021 Added 32.57%	81,495 $993,000
Q1 2021 May 13, 2021	SELL	$22.23 - $34.75 $45,904 - $71,758	-2,065 Reduced 3.25%	61,474 $1.49 Million
Q4 2020 Feb 09, 2021	BUY	$29.47 - $35.0 $145,404 - $172,690	4,934 Added 8.42%	63,539 $2.04 Million
Q3 2020 Nov 12, 2020	BUY	$26.17 - $43.07 $316,028 - $520,113	12,076 Added 25.95%	58,605 $1.77 Million
Q2 2020 Aug 12, 2020	BUY	$22.3 - $44.8 $358,628 - $720,473	16,082 Added 52.82%	46,529 $1.96 Million
Q1 2020 May 06, 2020	BUY	$18.18 - $39.48 $553,526 - $1.2 Million	30,447 New	30,447 $759,000

47.6M

2.9K

69.4K

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $68.7M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.